Western Sydney Diabetes, Western Sydney Local Health District, Blacktown NSW, Australia.
School of Health and Society, University of Wollongong, Wollongong, Australia.
J Med Internet Res. 2020 Sep 29;22(9):e20283. doi: 10.2196/20283.
Chronic disease represents a large and growing burden to the health care system worldwide. One method of managing this burden is the use of app-based interventions; however attrition, defined as lack of patient use of the intervention, is an issue for these interventions. While many apps have been developed, there is some evidence that they have significant issues with sustained use, with up to 98% of people only using the app for a short time before dropping out and/or dropping use down to the point where the app is no longer effective at helping to manage disease.
Our objectives are to systematically appraise and perform a meta-analysis on dropout rates in apps for chronic disease and to qualitatively synthesize possible reasons for these dropout rates that could be addressed in future interventions.
MEDLINE (Medical Literature Analysis and Retrieval System Online), PubMed, Cochrane CENTRAL (Central Register of Controlled Trials), and Embase were searched from 2003 to the present to look at mobile health (mHealth) and attrition or dropout. Studies, either randomized controlled trials (RCTs) or observational trials, looking at chronic disease with measures of dropout were included. Meta-analysis of attrition rates was conducted in Stata, version 15.1 (StataCorp LLC). Included studies were also qualitatively synthesized to examine reasons for dropout and avenues for future research.
Of 833 studies identified in the literature search, 17 were included in the review and meta-analysis. Out of 17 studies, 9 (53%) were RCTs and 8 (47%) were observational trials, with both types covering a range of chronic diseases. The pooled dropout rate was 43% (95% CI 29-57), with observational studies having a higher dropout rate (49%, 95% CI 27-70) than RCTs in more controlled scenarios, which only had a 40% dropout rate (95% CI 16-63). The studies were extremely varied, which is represented statistically in the high degree of heterogeneity (I>99%). Qualitative synthesis revealed a range of reasons relating to attrition from app-based interventions, including social, demographic, and behavioral factors that could be addressed.
Dropout rates in mHealth interventions are high, but possible areas to minimize attrition exist. Reducing dropout rates will make these apps more effective for disease management in the long term.
International Prospective Register of Systematic Reviews (PROSPERO) CRD42019128737; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128737.
慢性病对全球医疗系统构成了巨大且不断增长的负担。管理这种负担的一种方法是使用基于应用程序的干预措施;然而,失访率(定义为患者未使用干预措施)是这些干预措施面临的一个问题。尽管已经开发了许多应用程序,但有证据表明,它们在持续使用方面存在严重问题,高达 98%的人在退出应用程序之前仅使用该应用程序很短的时间,或者将使用频率降低到应用程序无法有效帮助管理疾病的程度。
我们的目标是系统地评估和对慢性病应用程序的失访率进行荟萃分析,并从定性上综合可能导致这些失访率的原因,以便在未来的干预措施中加以解决。
从 2003 年到现在,我们在 MEDLINE(医学文献分析和检索系统在线)、PubMed、Cochrane CENTRAL(对照试验中央注册库)和 Embase 中搜索了移动健康(mHealth)和失访或辍学的相关文献。纳入了研究包括随机对照试验(RCTs)和观察性试验,这些研究均针对患有慢性病且有失访率测量的患者。使用 Stata 版本 15.1(StataCorp LLC)对失访率进行了荟萃分析。纳入的研究也进行了定性综合,以检查失访的原因和未来研究的途径。
在文献检索中,共确定了 833 项研究,其中 17 项纳入了综述和荟萃分析。在 17 项研究中,9 项(53%)为 RCTs,8 项(47%)为观察性试验,涵盖了一系列慢性疾病。总的失访率为 43%(95%CI 29-57),观察性研究的失访率(49%,95%CI 27-70)高于 RCTs 更受控的情景,RCTs 的失访率仅为 40%(95%CI 16-63)。这些研究差异极大,在统计上表现为高度异质性(I>99%)。定性综合揭示了与基于应用程序的干预措施失访相关的一系列原因,包括可能解决的社会、人口统计学和行为因素。
移动健康干预措施的失访率很高,但存在减少失访的可能途径。降低失访率将使这些应用程序在长期内更有效地管理疾病。
国际前瞻性系统评价注册库(PROSPERO)CRD42019128737;https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128737。